1
|
Karshieva SS, Glinskaya EG, Dalina AA, Akhlyustina EV, Makarova EA, Khesuani YD, Chmelyuk NS, Abakumov MA, Khochenkov DA, Mironov VA, Meerovich GA, Kogan EA, Koudan EV. Antitumor activity of photodynamic therapy with tetracationic derivative of synthetic bacteriochlorin in spheroid culture of liver and colon cancer cells. Photodiagnosis Photodyn Ther 2022; 40:103202. [PMID: 36400167 DOI: 10.1016/j.pdpdt.2022.103202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2022] [Revised: 10/27/2022] [Accepted: 11/14/2022] [Indexed: 11/17/2022]
Abstract
Efficient screening of photosensitizers (PS) as well as studying their photodynamic activity, especially PS excited in the near-infrared region, require informative in vitro models to adequately reflect the architecture, thickness, and intercellular interactions in tumors. In our study, we used spheroids formed from human colon cancer HCT-116 cells and liver cancer Huh7 cells to assess the phototoxicity of a new PS based on tetracationic derivative of synthetic bacteriochlorin (BC4). We optimized conditions for the irradiation regime based on the kinetics of BC4 accumulation in spheroids and kinetics of spheroid growth. Although PS accumulated more efficiently in HCT-116 cells, characterized by more aggressive growth and high proliferative potential, they were less susceptible to the photodynamic therapy (PDT) compared to the slower growing Huh7 cells. We also showed that 3D models of spheroids were less sensitive to BC4 than conventional 2D cultures with relatively identical kinetics of drug accumulation. Our findings suggest that BC4 is a perspective agent for photodynamic therapy against cancer cells.
Collapse
Affiliation(s)
- Saida Sh Karshieva
- National University of Science and Technology MISIS, Leninskiy pr. 4, Moscow 119049, Russia; N N Blokhin National Medical Research Center of Oncology, Kashirskoe shosse 24, Moscow 115478, Russia
| | - Elizaveta G Glinskaya
- I M Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya str. 8-2, Moscow 119992, Russia
| | - Alexandra A Dalina
- The Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences, Vavilov st. 32, Moscow 119991, Russia
| | | | - Elena A Makarova
- Organic Intermediates and Dyes Institute, B. Sadovaya st. 1/4, Moscow 123001, Russia
| | - Yusef D Khesuani
- Laboratory for Biotechnological Research "3D Bioprinting Solutions", Kashirskoe shosse 68, Moscow 115409, Russia
| | - Nelly S Chmelyuk
- National University of Science and Technology MISIS, Leninskiy pr. 4, Moscow 119049, Russia; Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ostrovityanova st. 1, Moscow 117997, Russia
| | - Maxim A Abakumov
- National University of Science and Technology MISIS, Leninskiy pr. 4, Moscow 119049, Russia; Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ostrovityanova st. 1, Moscow 117997, Russia
| | - Dmitriy A Khochenkov
- N N Blokhin National Medical Research Center of Oncology, Kashirskoe shosse 24, Moscow 115478, Russia; Togliatti State University, Belorusskaya st. 14, Togliatti 445667, Russia
| | - Vladimir A Mironov
- National University of Science and Technology MISIS, Leninskiy pr. 4, Moscow 119049, Russia; I M Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya str. 8-2, Moscow 119992, Russia; National Research Nuclear University "MEPhI", Kashirskoe shosse 31, Moscow 115409, Russia
| | - Gennady A Meerovich
- National Research Nuclear University "MEPhI", Kashirskoe shosse 31, Moscow 115409, Russia; Prokhorov General Physics Institute of the Russian Academy of Sciences, Moscow, Vavilov st. 38, Moscow 119991, Russia
| | - Evgeniya A Kogan
- I M Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya str. 8-2, Moscow 119992, Russia
| | - Elizaveta V Koudan
- National University of Science and Technology MISIS, Leninskiy pr. 4, Moscow 119049, Russia; National Research Nuclear University "MEPhI", Kashirskoe shosse 31, Moscow 115409, Russia.
| |
Collapse
|
2
|
Moghassemi S, Dadashzadeh A, Azevedo RB, Feron O, Amorim CA. Photodynamic cancer therapy using liposomes as an advanced vesicular photosensitizer delivery system. J Control Release 2021; 339:75-90. [PMID: 34562540 DOI: 10.1016/j.jconrel.2021.09.024] [Citation(s) in RCA: 37] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2021] [Revised: 09/16/2021] [Accepted: 09/18/2021] [Indexed: 12/26/2022]
Abstract
The multidisciplinary field of photodynamic therapy (PDT) is a combination of photochemistry and photophysics sciences, which has shown tremendous potential for cancer therapy application. PDT employs a photosensitizing agent (PS) and light to form cytotoxic reactive oxygen species and subsequently oxidize light-exposed tissue. Despite numerous advantages of PDT and enormous progress in this field, common PSs are still far from ideal treatment because of their poor permeability, non-specific phototoxicity, side effects, hydrophobicity, weak bioavailability, and tendency to self-aggregation. To circumvent these limitations, PS can be encapsulated in liposomes, an advanced drug delivery system that has demonstrated the ability to enhance drug permeability into biological membranes and loading both hydrophobic and lipophilic agents. Moreover, liposomes can also be coated by targeting agents to improve delivery efficiency. The present review aims to summarize the principles of PDT, various PS generations, PS-loaded nanoparticles, liposomes, and their impact on PDT, then discuss recent photodynamic cancer therapy strategies using liposomes as PS-loaded vectors, and highlight future possibilities and perspectives.
Collapse
Affiliation(s)
- Saeid Moghassemi
- Pôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium
| | - Arezoo Dadashzadeh
- Pôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium
| | - Ricardo Bentes Azevedo
- Laboratory of Nanobiotechnology, Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasília, Brasília, DF, Brazil
| | - Olivier Feron
- Pôle de Pharmacologie et thérapeutique, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium
| | - Christiani A Amorim
- Pôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
| |
Collapse
|
3
|
Chen L, Chen M, Zhou Y, Ye C, Liu R. NIR Photosensitizer for Two-Photon Fluorescent Imaging and Photodynamic Therapy of Tumor. Front Chem 2021; 9:629062. [PMID: 33708758 PMCID: PMC7940671 DOI: 10.3389/fchem.2021.629062] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2020] [Accepted: 01/19/2021] [Indexed: 01/10/2023] Open
Abstract
Preparation of near-infrared (NIR) emissive fluorophore for imaging-guided PDT (photodynamic therapy) has attracted enormous attention. Hence, NIR photosensitizers of two-photon (TP) fluorescent imaging and photodynamic therapy are highly desirable. In this contribution, a novel D-π-A structured NIR photosensitizer (TTRE) is synthesized. TTRE demonstrates near-infrared (NIR) emission, good biocompatibility, and superior photostability, which can act as TP fluorescent agent for clear visualization of cells and vascular in tissue with deep-tissue penetration. The PDT efficacy of TTRE as photosensitizer is exploited in vitro and in vivo. All these results confirm that TTRE would serve as potential platform for TP fluorescence imaging and imaging-guided photodynamic therapy.
Collapse
Affiliation(s)
- Lujia Chen
- Breast Center, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China
| | - Meijuan Chen
- State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Hepatology Unit and Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China
| | - Yuping Zhou
- Guangdong Provincial Key Laboratory of Medical Image Processing, School of Biomedical Engineering, Southern Medical University, Guangzhou, China
| | - Changsheng Ye
- Breast Center, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China
| | - Ruiyuan Liu
- Guangdong Provincial Key Laboratory of Medical Image Processing, School of Biomedical Engineering, Southern Medical University, Guangzhou, China
| |
Collapse
|